About

Nov 14-15, 2022    Dubai, UAE

2nd International Conference on

Pharmacovigilance, Drug safety, Discovery and Design

About Longdom Conferences

Longdom conferences hosting 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Pharmacovigilance and Drug safety research, Longdom meetings is hosting its “2nd International Conference on Pharmacovigilance and Drug safety”. This is scheduled for November 14 -15, 2022 in Dubai,UAE. The field of Pharmacovigilance and Drug safety are one of newest scientific subjects, which are continuously evolving and have placed many landmarks in different research and development sectors. These fields are ecological science, agronomy, healthcare, drug discovery, food technology, and many other industrial areas. The Pharmacovigilance and Drug safety conference 2022 extends immense pleasure in inviting you to join us at this conference which will be focusing on the theme “Exploring Latest Trends in Pharmacovigilance and Drug Safety ”. We aim to engage, empower, evolve, and explore knowledge among attendees from all levels of scientific research on mycology. This mycology and mushroom conference will be focussing on the core knowledge and major advances in the rapidly emerging fields by attracting eminent scholars, experts, and professionals globally.

Why join LONGDOM conferences?

Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore

Who will be the participants?

Academic Deans and Directors | Professors and project leads | Postdocs and research scholars | Young scientists and students | CEOs/ CFOs/ Chairs/ Vice-Chairs | Marketing/ business and development teams | Experts who are keen-sighted for collaboration | Product designers and resolution workers | Business sales & services professionals | Associations and society members | Funding organizations & fundraisers

Engage, Evolve and Empower both Academia and  Industry.

Important Scientific Sessions

Track 1: Pharmacovigilance and Risk Management

Pharmacovigilance and Risk Management comprises set of pharmacovigilance conditioning and interventions designed to identify, characterise, help or minimise pitfalls relating to medicinal and remedial products including the assessment of the effectiveness of their clinical interventions and combination curatives. Medicine assiduity need to promote companies in pharmacovigilance practice to use information technology and to review software’s used in pharmacovigilance and clinical trials. Monitoring unlicensed, off markers and orphan medicines is major task in threat operation. Numerous experts from different pharmacovigilance CRO’s pharmacovigilance service providers and artificial delegates are sharing in this conference to partake their knowledge and bandy about the new updates.

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences.

Related Associations or Societies:

Societies in USA: International Society of Pharmacovigilance | Drug Safety & Pharmacovigilance | Association of Clinical Research Professionals (ACRP) | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | the Society of Clinical Research Associates (SOCRA) | Society for Clinical Trials (SCT) | Canadian Association of Professionals in Regulatory Affairs | Clinical Research Society (CRS)

Track 2: Drug Safety

Drug Safety heavily focuses on adverse medicine responses which are defined as any response to a medicine which is noxious and unintended, including lack of efficacity. drug crimes similar as overdose, and abuse and abuse of a medicine as well as medicine exposure during gestation and breastfeeding, are also of interest, indeed without an adverse event, because they may affect in an adverse medicine response. Information entered from cases and healthcare providers via pharmacovigilance agreements (PVAs), as well as other sources similar as the medical literature, plays a critical part in furnishing the data necessary for pharmacovigilance to take place. Eventually, medicine safety is concerned with relating the hazards associated with pharmaceutical products and with minimizing the threat of any detriment that may come to cases. Companies must conduct a comprehensive medicine safety and pharmacovigilance inspection to assess their compliance with worldwide laws, regulations, and guidance.

Top Conferences:

Pharmacovigilance 2022 | Pharmacovigilance Events | Drug Safety Conferences | Scientific Conferences on Pharmacovigilance | Best Pharma Podcasts 2022 | Clinical Trials 2022 | Pharmacovigilance Dubai Conferences | Pharma 2022 Dubai Events

Best Associations or Societies:

European Association for Clinical Pharmacology (EACPT) | International Society of Pharmacovigilance (ISOP) | European Medicines Agency, Pharmaceutical Information and Pharmacovigilance Association (PIPA) | Association of CROs Czech Republic (ACRO-CZ) | European Clinical Research Infrastructures Network (ECRIN) | European Society for Clinical Investigation (ESCI).

Track 3: Pre- Clinical and Clinical Trials

Clinical trials allow the medicine to be tested for safety by different ethnical population. In medicine development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of exploration that begins before clinical trials( testing in humans) can begin, and during which important feasibility, iterative testing and medicine safety data are collected. The main pretensions of pre-clinical studies are to determine the safe cure for first- in- man study and assess a product's safety profile. Products may include new medical bias, medicines, gene remedy results and individual tools.

Related Conferences:

Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference

Related Associations or Societies:

Societies in Asia and Pacific: Society of Pharmacovigilance, International Society of Pharmacovigilance: (ISOP) | Indian Society for Clinical Organization Research (ISCR) | Indian Society for Clinical Research | Clinical Trials Society | Society for Clinical Trials Association of Clinical Research | The Society of Clinical Research Associates | Association of Clinical Research Organization | Clinical Research Society | Indian Council of Medical Research (ICMR) | Japan CRO Association (JCROA) | Pan-Asian Clinical Research Association (PACRA) | Central Society for Clinical and Translational Research (CSCTR)

Track 4: Adverse medicine responses

Adverse medicine responses can be considered a form of toxin or enhanced medicine goods that do during applicable use (eg, when medicine metabolism is temporarily inhibited by a complaint or another medicine). In the US, 3 to 7 of all hospitalizations are due to adverse medicine responses. ADRs do during 10 to 20 of hospitalizations; about 10 to 20 of these ADRs are severe. Prevalence of death due to ADRs is unknown; suggested rates of0.5 to0.9 may be falsely high because numerous of the cases included had serious and complex diseases. Prevalence and inflexibility of adverse medicine responses vary by patient characteristics (eg, age, coitus, race, coinciding diseases, inheritable or geographic factors) and by medicine factors( eg, type of medicine, administration route, treatment duration, lozenge, and bioavailability. Prevalence is advanced with advanced age and polypharmacy.

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

Related Associations or Societies:

International Society of Pharmacovigilance | Drug Safety & Pharmacovigilance | Association of Clinical Research Professionals (ACRP) | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | the Society of Clinical Research Associates (SOCRA) | Society for Clinical Trials (SCT) | Canadian Association of Professionals in Regulatory Affairs | Clinical Research Society (CRS)

Track 5: Importance of Pharmacovigilance in Pandemic situation- COVID- 19

Covid has handed colourful challenges as well as openings for Pharmacovigilance service providers. During Coronavirus lockdowns there was a decline in on-going clinical trials due to the defined vacuity of clinical coffers and exploration staff. The restriction of cases also brought changed work practices, routine check-ups and safety examinations. Also, an increase in the use of medicines either approved for Covid or off marker use) have driven the healthcare assiduity to work round the timepiece for safety profiling of the products. To be suitable to work similar growth openings, the Pharmacovigilance assiduity is decreasingly conforming to new trends attributed to better and further effective data collection and analysis.

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

Related Associations or Societies:

European Association for Clinical Pharmacology (EACPT) | International Society of Pharmacovigilance (ISOP) | European Medicines Agency, Pharmaceutical Information and Pharmacovigilance Association (PIPA) | Association of CROs Czech Republic (ACRO-CZ) | European Clinical Research Infrastructures Network (ECRIN) | European Society for Clinical Investigation (ESCI).

Track 6: Forensic Science and Toxicology

Forensic toxicology is the analysis of natural samples for the presence of poisons, including medicines. The toxicology report can give crucial information as to the type of substances present in an individual and if the quantum of those substances is harmonious with a remedial lozenge or is above a dangerous position.

Related Conferences:

Case Study Conferences | Pharmacovigilance and Drug Safety Meetings | Adverse Drug Reactions Conferences | Pharmacovigilance Practices Conferences | Pharmacy Practices Conferences | Risk Management and Pharmacovigilance Conferences | Challenges in Clinical Trials Conferences | Pharmacology and Pharmacovigilance Conferences | Clinical Trials and Drug Safety Conferences | Global Clinical Trials Conferences

Related Associations or Societies:

Societies in Europe:  European Association for Clinical Pharmacology (EACPT) | International Society of Pharmacovigilance (ISOP) | European Medicines Agency, Pharmaceutical Information and Pharmacovigilance Association (PIPA) | Association of CROs Czech Republic (ACRO-CZ) | European Clinical Research Infrastructures Network (ECRIN) | European Society for Clinical Investigation (ESCI).

Track 7: pharmacotherapeutics

Pharmacotherapeutics is the use of medicines for the forestallment, treatment and opinion of conditions and for revision of normal functions (gestation forestallment). This field associates pharmacodynamics and pharmacokinetics with biochemical and microbiologic angles of conditions.

Pharmacotherapeutics examines the medium of action of medicines. It explains the goods produced by medicines. It determines the lozenge of medicine to be given to produce a specific effect etc.

Related Conferences:

Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference

Related Associations or Societies:

International Society of Pharmacovigilance | Drug Safety & Pharmacovigilance | Association of Clinical Research Professionals (ACRP) | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | the Society of Clinical Research Associates (SOCRA) | Society for Clinical Trials (SCT) | Canadian Association of Professionals in Regulatory Affairs | Clinical Research Society (CRS)

 

Track 8: Pharmacovigilance Significance & Scope

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient weal and public health and to know what pharmacovigilance is. This track gives a brief discussion on Pharmacovigilance part in healthcare system. Pharmacovigilance legislation gives an outlook on the rules and laws to follow in Pharmacovigilance practice. The part of Pharma diligence in the enhancement of pharmacovigilance system is veritably pivotal to maintain the safety data, Discovery and Evaluation of medicine safety signals through homemade and medical bias reporting. Pharmacovigilance compass also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal drugs.

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

Related Associations or Societies:

Society of Pharmacovigilance, International Society of Pharmacovigilance: (ISOP) | Indian Society for Clinical Organization Research (ISCR) | Indian Society for Clinical Research | Clinical Trials Society | Society for Clinical Trials Association of Clinical Research | The Society of Clinical Research Associates | Association of Clinical Research Organization | Clinical Research Society | Indian Council of Medical Research (ICMR) | Japan CRO Association (JCROA) | Pan-Asian Clinical Research Association (PACRA) | Central Society for Clinical and Translational Research (CSCTR)

Track 9: Good Pharmacovigilance Practice

The part of Good Pharmacovigilance Practice and Pharmacoepidemiology in Risk Management is substantially to increase the probability of salutary goods of a medicine in a population than the probability of adverse goods and to maintain the Good Reporting Practices by avoiding the major problems in threat operation. Also it's important to concentrate on Signal disquisition by gathering the information on new or unknown medicine goods that's potentially caused by a drug and that eventually should lead to icing safety. The pharmacovigilance and clinical trials services furnishing companies should have the Pharmacovigilance instrument.

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences.

Related Associations or Societies:

The Society of Clinical Research Associates (SOCRA) | Society for Clinical Trials (SCT) | Canadian Association of Professionals in Regulatory Affairs | Clinical Research Society (CRS) | International Society of Pharmacovigilance | Drug Safety & Pharmacovigilance | Association of Clinical Research Professionals (ACRP) | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry |

Track 10: Pharmacy Practices and its Challenges

Drugstore practice is the field of drugstore which involves developing the professional places of druggists. It includes Disease- state operation, Clinical medicine interventions, drugstore professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, medicine abuse forestallment, forestallment of medicine relations or minimisation of adverse events and medicine incompatibility and community drugstore.

Related Conferences:

Case Study Conferences | Pharmacovigilance and Drug Safety Meetings | Adverse Drug Reactions Conferences | Pharmacovigilance Practices Conferences | Pharmacy Practices Conferences | Risk Management and Pharmacovigilance Conferences | Challenges in Clinical Trials Conferences | Pharmacology and Pharmacovigilance Conferences | Clinical Trials and Drug Safety Conferences | Global Clinical Trials Conferences.

Related Associations or Societies:

Association of CROs Czech Republic (ACRO-CZ) | European Clinical Research Infrastructures Network (ECRIN) | European Society for Clinical Investigation (ESCI) | European Association for Clinical Pharmacology (EACPT) | International Society of Pharmacovigilance (ISOP) | European Medicines Agency, Pharmaceutical Information and Pharmacovigilance Association (PIPA)

Track 11: Biopharmaceutical Sciences

In Clinical Pharmacology and Bio pharmaceutics track we will bandy about the rational medicine operation of cancer, diabetes and cardiovascular diseases, and operation of psychiatric diseases and autoimmune diseases. Along with clinical trials Bioavailability and bioequivalence studies also plays major part in clinical exploration. The global request for Bio pharmaceutics in 2013 was$305.1 million, which is anticipated to reach about$326.3 million by time- end 2014. The projected PAT instrumentation request is anticipated to be valued at around$450.6 million by 2019 at a composite periodic

Related Conferences:

Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences  Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference

Related Associations or Societies:

Society of Pharmacovigilance, International Society of Pharmacovigilance: (ISOP) | Indian Society for Clinical Organization Research (ISCR) | Indian Society for Clinical Research | Clinical Trials Society | Society for Clinical Trials Association of Clinical Research | The Society of Clinical Research Associates | Association of Clinical Research Organization | Clinical Research Society | Indian Council of Medical Research (ICMR) | Japan CRO Association (JCROA) | Pan-Asian Clinical Research Association (PACRA) | Central Society for Clinical and Translational Research (CSCTR)

Track 12: Data Quality Management and Analysis

Good data quality operation in pharmacovigilance can be reckoned only on information gathered from the collection of individual case safety reports and other pharmacoepidemiological data. Quality operation consists of quality planning, quality control, quality assurance and quality advancements. The pharmacovigilance data processing cycle starts with data collection and, in computerised systems, data entry; the coming step is data storehouse and conservation; followed by data selection, reclamation and manipulation. The performing data affair is analysed and assessed. Eventually, conclusions are drawn and opinions are made. The quality of a pharmacovigilance data system can be defined as a measure of excellence or a state of being free from blights, scarcities and significant variations and the data quality operation includes all the conditioning that associations use to direct, control and coordinate the quality of data.

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practice Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

Related Associations or Societies:

Society of Pharmacovigilance, International Society of Pharmacovigilance: (ISOP) | Indian Society for Clinical Organization Research (ISCR) | Indian Society for Clinical Research | Clinical Trials Society | Society for Clinical Trials Association of Clinical Research | The Society of Clinical Research Associates | Association of Clinical Research Organization | Clinical Research Society | Indian Council of Medical Research (ICMR) | Japan CRO Association (JCROA) | Pan-Asian Clinical Research Association (PACRA) | Central Society for Clinical and Translational Research (CSCTR)

  [email protected]
  [email protected]
  [email protected]
Speakers Interview